Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 2/20 | 0.59 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.59 |
| ▸ | THRB | P10828 | 1/20 | 0.59 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.59 |
| ▸ | NFKB1 | P19838 | 1/20 | 0.59 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.59 |
| ▸ | THPO | P40225 | 1/20 | 0.59 |
| ▸ | RECQL | P46063 | 1/20 | 0.59 |
| ▸ | BLM | P54132 | 1/20 | 0.59 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.59 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.57 |
| ▸ | FOLH1 | Q04609 | 5/20 | 0.43 |
| ▸ | NAALAD2 | Q9Y3Q0 | 3/20 | 0.43 |
| ▸ | RIMKLA | Q8IXN7 | 1/20 | 0.43 |
| ▸ | PRNP | P04156 | 1/20 | 0.40 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.40 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.40 |
| ▸ | LMNA | P02545 | 2/20 | 0.40 |
| ▸ | GNPAT | O15228 | 1/20 | 0.40 |
| ▸ | PAM | P19021 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13921443 | 1.00 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL6658481 | 1.00 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL25329304 | 0.86 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL16745722 | 0.86 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL2140974 | 0.86 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL24067699 | 0.86 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL308082 | 0.86 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL31405642 | 0.86 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL6308419 | 0.86 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 | |
| SCHEMBL308083 | 0.86 | MAPT (0.59) | MAPTKDM4ETHRBALOX15NFKB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 122 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-110946772-A | Toothpaste for preventing dental diseases and preparation method thereof | 苏格格 | 2020-04-03 | — | — | CN | claimed |
| US-20030162732-A1 | Combination of aminosugars and cysteine or cysteine derivatives | ASTION DEVELOPMENT A/S (DK) | 2003-08-28 | — | — | US | claimed |
| US-20030158118-A1 | Combination of cimetidine and cysteine derivatives for treating cancer | WEIDNER MORTEN SLOTH (DK) | 2003-08-21 | — | — | US | claimed |
| WO-2003045359-A2 | COMBINATION OF CIMETIDINE AND CYSTEINE DERIVATIVES FOR TREATING CANCER | ASTION ONCOLOGY APS (DK) | 2003-06-05 | — | — | WO | claimed |
| WO-2003002125-A2 | COMBINATION OF AMINOSUGARS AND CYSTEINE OR CYSTEINE DERIVATIVES | ASTION A/S (DK) | 2003-01-09 | — | — | WO | claimed |
| US-20260102334-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM LTD (IL) | 2026-04-16 | — | — | US | disclosed |
| US-20250073193-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM LTD (IL) | 2025-03-06 | — | — | US | disclosed |
| CN-113274579-B | Device for subcutaneous delivery of fluid drugs | 纽罗德姆有限公司 | 2024-02-13 | — | — | CN | disclosed |
| EP-4299128-A2 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | Neuroderm Ltd. (IL) | 2024-01-03 | — | — | EP | disclosed |
| US-20230240980-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM LTD (IL) | 2023-08-03 | — | — | US | disclosed |
| US-20230096364-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | NEURODERM LTD (IL) | 2023-03-30 | — | — | US | disclosed |
| CN-113274578-B | Device for subcutaneous delivery of fluid drugs | 纽罗德姆有限公司 | 2022-06-03 | — | — | CN | disclosed |
| EP-0373339-A1 | Silver halide recording material | Agfa-Gevaert AG (DE) | 1990-06-20 | — | — | EP | disclosed |
| US-4482495-A | CHEMICAL INTERMEDIATES FOR ANALGESICS | STERLING DRUG INC. (US) | 1984-11-13 | — | — | US | disclosed |
| EP-0051682-B1 | CYSTEINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | MITSUBISHI KASEI CORPORATION (JP) | 1984-09-05 | — | — | EP | disclosed |
| US-4440788-A | REGENERATION OF LIVER CELLS | MITSUBISHI CHEMICAL INDUSTRIES, LIMITED (JP) | 1984-04-03 | — | — | US | disclosed |
| US-4405800-A | ANALGESICS | STERLING DRUG INC. (US) | 1983-09-20 | — | — | US | disclosed |
| US-4361703-A | ANALGESICS | STERLING DRUG INC. (US) | 1982-11-30 | — | — | US | disclosed |
| EP-0051682-A1 | CYSTEINE DERIVATIVES AND PROCESS FOR THEIR PREPARATION | MITSUBISHI KASEI CORPORATION (JP) | 1982-05-19 | — | — | EP | disclosed |
| US-4181719-A | Analgesic N-acetyl-para-aminophenyl N'-acetylaminothioalkanoates | STERLING DRUG INC. (US) | 1980-01-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030162732-A1 | Combination of aminosugars and cysteine or cysteine derivatives | CBS, CTH, AADAT | MAPT 2801/4885KDM4E 3811/4885THRB 4391/4885 |
| US-20230096364-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | DDT, DDC, COMT | MAPT 888/4885KDM4E 1869/4885THRB 1305/4885 |
| US-20030158118-A1 | Combination of cimetidine and cysteine derivatives for treating cancer | MGMT, CMA1, CYSLTR2 | MAPT 4793/4885KDM4E 2224/4885THRB 4256/4885 |
| US-20260102334-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | COMT, PARK7, DDT | MAPT 792/4885KDM4E 656/4885THRB 3145/4885 |
| US-20250073193-A1 | DOPA DECARBOXYLASE INHIBITOR COMPOSITIONS | DDT, DDC, COMT | MAPT 888/4885KDM4E 1869/4885THRB 1305/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.